Two Sigma Securities’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Two Sigma Securities’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,782	Closed	-$277K	–	3837
2024 Q2	$277K	Buy	+6,782	New	+$282K	﹤0.01%	2059

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Two Sigma Securities's CERE Position: Q3 2024 in Review

Two Sigma Securities sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 6,782 shares — an estimated $277K sold.

Two Sigma Securities first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $277K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Two Sigma Securities reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 6,782 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $277K.
Two Sigma Securities first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Two Sigma Securities's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $277K in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.